Trial Profile
Metronomic chemiotherapic treatment WITH IRINOTECAN Cpt-11 IN PATIENTS WITH metastatic colon-rectal cancer PHARMACODYNAMIC And PHARMACOKINETIC evaluation.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 03 Jun 2011
Price :
$35
*
At a glance
- Drugs Irinotecan (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Acronyms CPTTS
- 03 Jun 2011 New trial record